77 related articles for article (PubMed ID: 7396995)
21. New detection of brain dopamine receptors with (3H)dihydroergocryptine.
Tittler M; Weinreich P; Seeman P
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3750-3. PubMed ID: 410026
[TBL] [Abstract][Full Text] [Related]
22. 3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors.
Creese I; Padgett L; Fazzini E; Lopez F
Eur J Pharmacol; 1979 Jul; 56(4):411-2. PubMed ID: 477735
[No Abstract] [Full Text] [Related]
23. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
Creese I; Burt DR; Snyder SH
Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
25. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
[TBL] [Abstract][Full Text] [Related]
26. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
Miller JC; Friedhoff AJ
Biochem Pharmacol; 1979 Mar; 28(5):688-90. PubMed ID: 444255
[No Abstract] [Full Text] [Related]
27. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
Goosey MW; Doggett NS
Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
[No Abstract] [Full Text] [Related]
28. Evidence for, and localization of, a unitary dopamine receptor composed of cooperatively linked subunit binding sites in rat striatum.
Leysen JE; Gommeren W; Laduron PM
Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):312-4. PubMed ID: 543764
[No Abstract] [Full Text] [Related]
29. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.
Wagner GC; Ricaurte GA; Seiden LS; Schuster CR; Miller RJ; Westley J
Brain Res; 1980 Jan; 181(1):151-60. PubMed ID: 7350950
[TBL] [Abstract][Full Text] [Related]
30. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.
Burt DR; Creese I; Snyder SH
Science; 1977 Apr; 196(4287):326-8. PubMed ID: 847477
[TBL] [Abstract][Full Text] [Related]
31. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
32. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
Seeman P; Chau-Wong M; Tedesco J; Wong K
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
[TBL] [Abstract][Full Text] [Related]
33. Conformation of dopamine at the dopamine receptor.
Komiskey HL; Bossart JF; Miller DD; Patil PN
Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2641-3. PubMed ID: 275833
[TBL] [Abstract][Full Text] [Related]
34. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Sumiyoshi T; Stockmeier CA; Overholser JC; Thompson PA; Meltzer HY
Brain Res; 1995 May; 681(1-2):109-16. PubMed ID: 7552267
[TBL] [Abstract][Full Text] [Related]
35. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
Richfield EK; Young AB; Penney JB
Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
[TBL] [Abstract][Full Text] [Related]
36. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.
Reisine TD; Rossor M; Spokes E; Iversen LL; Yamamura HI
Adv Biochem Psychopharmacol; 1980; 21():443-50. PubMed ID: 6246753
[No Abstract] [Full Text] [Related]
37. Dopamine D1 receptor in rat brain: a quantitative autoradiographic study with 125I-SCH 23982.
Aiso M; Shigematsu K; Kebabian JW; Potter WZ; Cruciani RA; Saavedra JM
Brain Res; 1987 Apr; 408(1-2):281-5. PubMed ID: 2954614
[TBL] [Abstract][Full Text] [Related]
38. Conversion of dopamine D1 receptors from high to low affinity for dopamine.
Seeman P; Ulpian C; Grigoriadis D; Pri-Bar I; Buchman O
Biochem Pharmacol; 1985 Jan; 34(1):151-4. PubMed ID: 3881100
[No Abstract] [Full Text] [Related]
39. Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine.
Titeler M; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):291-2. PubMed ID: 477726
[No Abstract] [Full Text] [Related]
40. The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
McKenzie GM
Adv Biochem Psychopharmacol; 1974; 12(0):339-51. PubMed ID: 4419524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
